# Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** Odonate Therapeutics, Inc.
- **Former names in filing history:** Odonate Therapeutics, LLC (2017-09-29 to 2017-12-06)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001717452

## About

Odonate Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001717452, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-02-23, it reported net income of USD -126,350,000; total assets of USD 167,886,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Net income:** -$126.3M (USD -126,350,000)
- **Total assets:** $167.9M (USD 167,886,000)
- **Operating cash flow:** -$113.1M (USD -113,130,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$111.8M (USD -111,825,000)
- **Total assets:** $188.8M (USD 188,827,000)
- **Operating cash flow:** -$96.6M (USD -96,638,000)

### FY2018 (period ended 2018-12-31)

- **Net income:** -$89.0M (USD -88,960,000)
- **Total assets:** $142.7M (USD 142,673,000)
- **Operating cash flow:** -$67.1M (USD -67,094,000)

## Recent SEC filings

- Form SC 13G — filed 2022-01-28 — NONE
- Form 8-K — filed 2022-01-07 — period 2022-01-06 — 8-K
- Form 8-K — filed 2021-11-18 — period 2021-11-17 — 8-K
- Form 10-Q — filed 2021-11-10 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-08-05 — period 2021-07-31 — 8-K
- Form 10-Q — filed 2021-07-27 — period 2021-06-30 — 10-Q
- Form SC 13G — filed 2021-07-19
- Form SC 13G — filed 2021-07-02 — SC 13G
- Form 8-K — filed 2021-06-25 — period 2021-06-24 — 8-K
- Form DEF 14A — filed 2021-06-01 — period 2021-06-24 — DEF 14A
- Form 10-Q — filed 2021-05-14 — period 2021-03-31 — 10-Q
- Form 8-K — filed 2021-03-25 — period 2021-03-19 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/odonate-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology